MAPT and Alzheimer disease: From the original description of AD by Alois Alzheimer in 1906, the pathology was described as the co-occurrence of extracellular plaques and intracellular neurofibrillary tangles (NFTs), subsequently shown to be composed of amyloid beta (Aβ) and the microtubule-associated protein tau, respectively [2].